Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Mori

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Clinical Calcium|October 1, 2011
[Calcium pros and cons: long term use of bisphosphonates. Bisphophonate should not be used for long term]Satoshi Mori
Clinical Calcium|December 4, 2004
[Contribution of bone quality to fracture risk]Satoshi Mori
Nihon Hoshasen Gijutsu Gakkai Zasshi|December 14, 2006
[Questions and answers of PET facilities: Part 3]Satoshi Mori
Clinical Calcium|July 2, 2013
[Bone micro-structural changes following osteoporotic drug treatment]Satoshi Mori
Nihon Hoshasen Gijutsu Gakkai Zasshi|January 20, 2007
[Questions and answers on PET facilities: part 4]Satoshi Mori
Clinical Calcium|June 2, 2012
[Concomitant treatment of the osteoporotic drugs]Satoshi Mori
Journal of Bone and Mineral Metabolism|March 22, 2025
Sequential therapy following teriparatide treatment in patients at high risk of osteoporotic patientsSatoshi Mori
Clinical Calcium|December 4, 2004
[Microdamage and bone quality]Satoshi Mori
Clinical Calcium|March 1, 2013
[SSBT (severely suppressed bone turnover) ]Satoshi Mori
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 11, 2005
[EBM of calcitonin]Satoshi Mori
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Clinical Calcium|October 1, 2011
[Calcium pros and cons: long term use of bisphosphonates. Bisphophonate should not be used for long term]Satoshi Mori
Clinical Calcium|December 4, 2004
[Contribution of bone quality to fracture risk]Satoshi Mori
Nihon Hoshasen Gijutsu Gakkai Zasshi|December 14, 2006
[Questions and answers of PET facilities: Part 3]Satoshi Mori
Clinical Calcium|July 2, 2013
[Bone micro-structural changes following osteoporotic drug treatment]Satoshi Mori
Nihon Hoshasen Gijutsu Gakkai Zasshi|January 20, 2007
[Questions and answers on PET facilities: part 4]Satoshi Mori
Clinical Calcium|June 2, 2012
[Concomitant treatment of the osteoporotic drugs]Satoshi Mori
Journal of Bone and Mineral Metabolism|March 22, 2025
Sequential therapy following teriparatide treatment in patients at high risk of osteoporotic patientsSatoshi Mori
Clinical Calcium|December 4, 2004
[Microdamage and bone quality]Satoshi Mori
Clinical Calcium|March 1, 2013
[SSBT (severely suppressed bone turnover) ]Satoshi Mori
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 11, 2005
[EBM of calcitonin]Satoshi Mori
Pageof 17